Cite
Preclinical antitumor activity of an antibody against the leukocyte antigen CD48.
MLA
Sun, H., et al. “Preclinical Antitumor Activity of an Antibody against the Leukocyte Antigen CD48.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 4, no. 4, Apr. 1998, pp. 895–900. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9563883&authtype=sso&custid=ns315887.
APA
Sun, H., Norris, B. J., Atkinson, K., Biggs, J. C., & Smith, G. M. (1998). Preclinical antitumor activity of an antibody against the leukocyte antigen CD48. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 4(4), 895–900.
Chicago
Sun, H, B J Norris, K Atkinson, J C Biggs, and G M Smith. 1998. “Preclinical Antitumor Activity of an Antibody against the Leukocyte Antigen CD48.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 4 (4): 895–900. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9563883&authtype=sso&custid=ns315887.